Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care.

Hirst JA, Montes MDV, Taylor CJ, Ordóñez-Mena JM, Ogburn E, Sharma V, Shine B, James T, Hobbs FR.

Br J Gen Pract. 2018 Jul 2. pii: bjgp18X697937. doi: 10.3399/bjgp18X697937. [Epub ahead of print]

PMID:
29970394
2.

Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 May 24;8(1):8354. doi: 10.1038/s41598-018-26376-7.

3.

Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net.

O'Sullivan JW, Heneghan C, Perera R, Oke J, Aronson JK, Shine B, Goldacre B.

Sci Rep. 2018 Mar 19;8(1):4752. doi: 10.1038/s41598-018-23263-z. Erratum in: Sci Rep. 2018 May 24;8(1):8354.

4.

Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.

Shah A, Wray K, James T, Shine B, Morovat R, Stanworth S, McKechnie S, Kirkbride R, Griffith DM, Walsh TS, Drakesmith H, Roy N.

Br J Haematol. 2018 Jan 24. doi: 10.1111/bjh.15067. [Epub ahead of print] No abstract available.

PMID:
29363744
5.

Falsely elevated plasma metanephrine in patients taking midodrine.

Emms H, Farah G, Shine B, Boot C, Toole B, McFadden M, Lam L, Ou ZQ, Woollard G, Madhavaram H, Kyle C, Grossman AB.

Ann Clin Biochem. 2018 Jul;55(4):509-515. doi: 10.1177/0004563218755817. Epub 2018 Feb 21.

PMID:
29357678
6.

Abiraterone acetate: a potential source of interference in testosterone assays.

Fairfax BP, Morgan RD, Protheroe A, Shine B, James T.

Clin Chem Lab Med. 2018 May 24;56(6):e138-e140. doi: 10.1515/cclm-2017-0631. No abstract available.

PMID:
29303767
7.

Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study.

Lasserson DS, Shine B, O'Callaghan CA, James T.

Br J Gen Pract. 2017 Oct;67(663):e732-e735. doi: 10.3399/bjgp17X692585. Epub 2017 Sep 11.

PMID:
28893765
8.

Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.

Sbardella E, Cranston T, Isidori AM, Shine B, Pal A, Jafar-Mohammadi B, Sadler G, Mihai R, Grossman AB.

Endocrine. 2018 Jan;59(1):175-182. doi: 10.1007/s12020-017-1310-9. Epub 2017 May 5.

PMID:
28477304
9.

Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays.

Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB.

Clin Endocrinol (Oxf). 2017 Feb;86(2):177-184. doi: 10.1111/cen.13232. Epub 2016 Oct 3.

PMID:
27616279
10.

Therapeutic drug monitoring in the era of precision medicine: opportunities!

Cremers S, Guha N, Shine B.

Br J Clin Pharmacol. 2016 Oct;82(4):900-2. doi: 10.1111/bcp.13047. No abstract available.

11.

Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014.

Quan TP, Fawcett NJ, Wrightson JM, Finney J, Wyllie D, Jeffery K, Jones N, Shine B, Clarke L, Crook D, Walker AS, Peto TE; Infections in Oxfordshire Research Database (IORD).

Thorax. 2016 Jun;71(6):535-42. doi: 10.1136/thoraxjnl-2015-207688. Epub 2016 Feb 17.

12.

Long-term effects of lithium on renal function--Authors' reply.

Shine B, McKnight R, Leaver L, Geddes J.

Lancet. 2015 Nov 14;386(10007):1944. doi: 10.1016/S0140-6736(15)00835-1. Epub 2015 Nov 13. No abstract available.

PMID:
26841751
13.

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

Perera R, McFadden E, McLellan J, Lung T, Clarke P, Pérez T, Fanshawe T, Dalton A, Farmer A, Glasziou P, Takahashi O, Stevens J, Irwig L, Hirst J, Stevens S, Leslie A, Ohde S, Deshpande G, Urayama K, Shine B, Stevens R.

Health Technol Assess. 2015 Dec;19(100):1-401, vii-viii. doi: 10.3310/hta191000. Review.

14.

Trends in serum creatinine testing in Oxfordshire, UK, 1993-2013: a population-based cohort study.

Oke J, Shine B, McFadden E, Stevens R, Lasserson D, Perera R.

BMJ Open. 2015 Dec 16;5(12):e009459. doi: 10.1136/bmjopen-2015-009459.

15.

Point-of-care testing of electrolytes and calcium using blood gas analysers: it is time we trusted the results.

Mirzazadeh M, Morovat A, James T, Smith I, Kirby J, Shine B.

Emerg Med J. 2016 Mar;33(3):181-6. doi: 10.1136/emermed-2015-204669. Epub 2015 Sep 22.

PMID:
26396233
16.

Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data.

Shine B, McKnight RF, Leaver L, Geddes JR.

Lancet. 2015 Aug 1;386(9992):461-8. doi: 10.1016/S0140-6736(14)61842-0. Epub 2015 May 20.

17.

Risk factors for mediastinitis following cardiac surgery: the importance of managing obesity.

Rehman SM, Elzain O, Mitchell J, Shine B, Bowler IC, Sayeed R, Westaby S, Ratnatunga C.

J Hosp Infect. 2014 Oct;88(2):96-102. doi: 10.1016/j.jhin.2014.06.011. Epub 2014 Jul 21.

PMID:
25123634
18.

Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach.

Yi G, Shine B, Rehman SM, Altman DG, Taggart DP.

Circulation. 2014 Aug 12;130(7):539-45. doi: 10.1161/CIRCULATIONAHA.113.004255. Epub 2014 Jun 10.

19.

Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.

Karuppiah D, Thanabalasingham G, Shine B, Wang LM, Sadler GP, Karavitaki N, Grossman AB.

Eur J Endocrinol. 2014 Jul;171(1):K1-5. doi: 10.1530/EJE-14-0166. Epub 2014 Apr 17.

20.

Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).

Rogers A, Nesbit MA, Hannan FM, Howles SA, Gorvin CM, Cranston T, Allgrove J, Bevan JS, Bano G, Brain C, Datta V, Grossman AB, Hodgson SV, Izatt L, Millar-Jones L, Pearce SH, Robertson L, Selby PL, Shine B, Snape K, Warner J, Thakker RV.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1300-5. doi: 10.1210/jc.2013-3909. Epub 2014 Apr 7.

21.

Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness.

Farmer AJ, Stevens R, Hirst J, Lung T, Oke J, Clarke P, Glasziou P, Neil A, Dunger D, M Colhoun H, Pugh C, Wong G, Perera R, Shine B.

Health Technol Assess. 2014 Feb;18(14):1-128. doi: 10.3310/hta18140. Review.

22.

The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK.

Hill NR, Lasserson D, Fatoba S, O'Callaghan CA, Pugh C, Perera-Salazar R, Shine B, Thompson B, Wolstenholme J, McManus R, Hobbs FD.

BMJ Open. 2013 Dec 17;3(12):e004265. doi: 10.1136/bmjopen-2013-004265.

23.

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.

Wainwright E, Sherrard J, Duncan S, Shine B, Dorrell L.

Int J STD AIDS. 2013 Jul;24(7):579-81. doi: 10.1177/0956462413476267. Epub 2013 Jul 8.

PMID:
23970775
24.

Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.

Rowland R, O'Hara GA, Hamill M, Poulton ID, Donaldson H, Dinsmore L, James T, Barnes E, Klenerman P, Gilbert SC, Hill AV, Shine B, McShane H.

Hum Vaccin Immunother. 2013 Aug;9(8):1741-51. doi: 10.4161/hv.24998. Epub 2013 Jun 3.

25.

Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, Oakley S, O'Connor L, Finney J, Vaughan A, Crook DW, Wilcox MH, Peto TE; Infections in Oxfordshire Research Database.

Clin Infect Dis. 2013 Jun;56(11):1589-600. doi: 10.1093/cid/cit127. Epub 2013 Mar 5.

26.

The role of the physician in laboratory medicine: a European perspective.

Misbah SA, Kokkinou V, Jeffery K, Oosterhuis W, Shine B, Schuh A, Theodoridis T.

J Clin Pathol. 2013 May;66(5):432-7. doi: 10.1136/jclinpath-2012-201042. Epub 2012 Dec 8.

PMID:
23223566
27.

Confusing genes: a patient with MEN2A and Cushing's disease.

Naziat A, Karavitaki N, Thakker R, Ansorge O, Sadler G, Gleeson F, Cranston T, McCormack A, Grossman AB, Shine B.

Clin Endocrinol (Oxf). 2013 Jun;78(6):966-8. doi: 10.1111/cen.12072. Epub 2013 Apr 6. No abstract available.

PMID:
23072303
28.

Diagnostic accuracy of urine dipstick testing in screening for microalbuminuria in type 2 diabetes: a cohort study in primary care.

Nagrebetsky A, Jin J, Stevens R, James T, Adler A, Park P, Craven A, Shine B, Farmer A.

Fam Pract. 2013 Apr;30(2):142-52. doi: 10.1093/fampra/cms057. Epub 2012 Sep 17. Erratum in: Fam Pract. 2013 Aug;30(4):481.

PMID:
22990027
29.

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting.

O'Callaghan CA, Shine B, Lasserson DS.

BMJ Open. 2011 Dec 19;1(2):e000308. doi: 10.1136/bmjopen-2011-000308. Print 2011.

30.

Facility fence-line monitoring using passive samplers.

Thoma ED, Miller MC, Chung KC, Parsons NL, Shine BC.

J Air Waste Manag Assoc. 2011 Aug;61(8):834-42.

PMID:
21874954
31.

Hyperglycemia and death in cystic fibrosis-related diabetes.

Adler AI, Shine B, Haworth C, Leelarathna L, Bilton D.

Diabetes Care. 2011 Jul;34(7):1577-8. doi: 10.2337/dc10-2289. Epub 2011 May 18.

32.

Neonatal plasma TSH--estimated upper reference intervals for diagnosis and follow up of congenital hypothyroidism.

Evans C, Neale S, Geen J, Jones G, Mannings L, Trow S, Brain A, Nix B, Ellis R, Hancock S, Shine B, Warner J, Gregory JW, Moat SJ.

Scand J Clin Lab Invest. 2011 Sep;71(5):394-8. doi: 10.3109/00365513.2011.575234. Epub 2011 May 5.

PMID:
21545246
33.

Local suture annuloplasty for posterior mitral valve repair: 18-year experience.

Soon JL, Du X, Shine B, Jin XY, Janas S, Pillai R.

Asian Cardiovasc Thorac Ann. 2011 Feb;19(1):20-6. doi: 10.1177/0218492310394665.

PMID:
21357313
34.

The rise of cholesterol testing: how much is unnecessary.

Doll H, Shine B, Kay J, James T, Glasziou P.

Br J Gen Pract. 2011 Feb;61(583):e81-8. doi: 10.3399/bjgp11X556245.

35.

Gene targeting through o-methylated catecholamine metabolite patterns.

Shine B.

Clin Chem. 2011 Mar;57(3):361-2. doi: 10.1373/clinchem.2010.159178. Epub 2011 Jan 18. No abstract available.

36.

Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years.

Edge JA, James T, Shine B.

Diabet Med. 2010 Nov;27(11):1284-8. doi: 10.1111/j.1464-5491.2010.03057.x.

PMID:
20950387
37.

Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.

Katulanda GW, Katulanda P, Adler AI, Peiris SR, Draisey I, Wijeratne S, Sheriff R, Matthews DR, Shine B.

Ann Clin Biochem. 2010 Jan;47(Pt 1):29-34. doi: 10.1258/acb.2009.009080. Epub 2009 Dec 1.

PMID:
19952033
38.

Diabetes as a determinant of mortality in cystic fibrosis.

Chamnan P, Shine BS, Haworth CS, Bilton D, Adler AI.

Diabetes Care. 2010 Feb;33(2):311-6. doi: 10.2337/dc09-1215. Epub 2009 Nov 16.

39.

Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.

Newey PJ, Jeyabalan J, Walls GV, Christie PT, Gleeson FV, Gould S, Johnson PR, Phillips RR, Ryan FJ, Shine B, Bowl MR, Thakker RV.

J Clin Endocrinol Metab. 2009 Oct;94(10):3640-6. doi: 10.1210/jc.2009-0564. Epub 2009 Jul 21.

PMID:
19622622
40.

An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.

Arnold DF, Burton J, Shine B, Wojnarowska F, Misbah SA.

Br J Dermatol. 2009 May;160(5):1098-102. doi: 10.1111/j.1365-2133.2009.09034.x. Epub 2009 Feb 16.

PMID:
19222460
41.

Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.

Ali I, James T, Meston N, Wojnarowska F, Shine B.

Clin Chem Lab Med. 2009;47(2):202-7. doi: 10.1515/CCLM.2009.049.

PMID:
19191727
42.

Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population.

Edge JA, James T, Shine B.

Diabet Med. 2008 Aug;25(8):942-8. doi: 10.1111/j.1464-5491.2008.02518.x.

PMID:
18959607
43.

Use of routine clinical laboratory data to define reference intervals.

Shine B.

Ann Clin Biochem. 2008 Sep;45(Pt 5):467-75. doi: 10.1258/acb.2008.008028.

PMID:
18753418
44.

Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.

Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D.

Diabetes Care. 2008 Sep;31(9):1789-94. doi: 10.2337/dc08-0466. Epub 2008 Jun 5.

45.

Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.

Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR.

Diabetologia. 2008 Aug;51(8):1368-74. doi: 10.1007/s00125-008-1052-6. Epub 2008 Jun 5.

PMID:
18528678
46.

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.

Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.

Eur J Endocrinol. 2008 Feb;158(2):265-71. doi: 10.1530/EJE-07-0485.

47.

What influences men's decision to have a prostate-specific antigen test? A qualitative study.

Rai T, Clements A, Bukach C, Shine B, Austoker J, Watson E.

Fam Pract. 2007 Sep;24(4):365-71. Epub 2007 Jul 21.

PMID:
17644829
48.

The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.

Clements A, Watson E, Rai T, Bukach C, Shine B, Austoker J.

BMC Fam Pract. 2007 Jun 25;8:35.

49.

Detecting overweight children in primary care: do national data reflect the typical urban practice?

Sutu E, Crespo CJ, Shine B, Doshi A, Quattrin T.

J Fam Pract. 2006 Nov;55(11):976-80.

PMID:
17090358
50.

Supplemental Content

Support Center